Insights

StrategicFit Therakos is now part of Mallinckrodt, indicating potential alignment for cross-selling between Therakos medical devices and Mallinckrodt's specialty pharmaceuticals and imaging agents, creating opportunities to bundle solutions for autoimmune, rare disease, and related therapies.

ExpGrowth Mallinckrodt's global footprint and diverse segments (Specialty Brands, Specialty Generics, Global Medical Imaging) combined with Therakos' niche medical device focus could unlock expansion into new markets and healthcare settings, including hospital and office-based physician channels.

EducationDb Recent ESOT collaboration signals a proactive commitment to education and knowledge sharing; this creates openings for joint sponsored education programs, clinical webinars, and research initiatives to drive adoption of Therakos therapies.

TechOps Existing tech stack elements (cloud, compliance, analytics, and process tooling) offer avenues to optimize sales operations, regulatory compliance workflows, and data-driven account targeting for healthcare providers and institutions.

FinancialLens Revenue bracket and private-market style data suggest a mid-market sales approach could be appropriate, with opportunities to position Therakos/Mallinckrodt offerings for mid-size hospitals and specialty clinics needing high-regulation medical materials and imaging support.

Similar companies to Therakos is now a part of Mallinckrodt Pharmaceuticals.

Therakos is now a part of Mallinckrodt Pharmaceuticals. Tech Stack

Therakos is now a part of Mallinckrodt Pharmaceuticals. uses 8 technology products and services including Modbus, Cloudflare, Mentor Graphics, and more. Explore Therakos is now a part of Mallinckrodt Pharmaceuticals.'s tech stack below.

  • Modbus
    Communications Technology
  • Cloudflare
    Content Management System
  • Mentor Graphics
    Dev Tools
  • ComplianceWire
    Education Management
  • TensorFlow
    Machine Learning
  • WPBakery
    Page Builders
  • Minitab
    Visualisation Software
  • Apache HTTP Server
    Web Servers

Therakos is now a part of Mallinckrodt Pharmaceuticals.'s Email Address Formats

Therakos is now a part of Mallinckrodt Pharmaceuticals. uses at least 1 format(s):
Therakos is now a part of Mallinckrodt Pharmaceuticals. Email FormatsExamplePercentage
First.Last@therakos.comJohn.Doe@therakos.com
89%
FirstLast@therakos.comJohnDoe@therakos.com
8%
FirLast@therakos.comJohDoe@therakos.com
2%
First_Last@therakos.comJohn_Doe@therakos.com
1%

Frequently Asked Questions

What is Therakos is now a part of Mallinckrodt Pharmaceuticals.'s phone number?

Minus sign iconPlus sign icon
You can contact Therakos is now a part of Mallinckrodt Pharmaceuticals.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Therakos is now a part of Mallinckrodt Pharmaceuticals.'s official website and social media links?

Minus sign iconPlus sign icon
Therakos is now a part of Mallinckrodt Pharmaceuticals.'s official website is therakos.com and has social profiles on LinkedIn.

How much revenue does Therakos is now a part of Mallinckrodt Pharmaceuticals. generate?

Minus sign iconPlus sign icon
As of July 2026, Therakos is now a part of Mallinckrodt Pharmaceuticals.'s annual revenue is estimated to be $1M - $10M.

What is Therakos is now a part of Mallinckrodt Pharmaceuticals.'s NAICS code?

Minus sign iconPlus sign icon
Therakos is now a part of Mallinckrodt Pharmaceuticals.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Therakos is now a part of Mallinckrodt Pharmaceuticals. have currently?

Minus sign iconPlus sign icon
As of July 2026, Therakos is now a part of Mallinckrodt Pharmaceuticals. has approximately 5K employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Executive Director, Compliance, Chief Compliance Officer: S. F.Territory Manager D/A/Ch: B. B.Director: C. F.. Explore Therakos is now a part of Mallinckrodt Pharmaceuticals.'s employee directory with LeadIQ.

What industry does Therakos is now a part of Mallinckrodt Pharmaceuticals. belong to?

Minus sign iconPlus sign icon
Therakos is now a part of Mallinckrodt Pharmaceuticals. operates in the Medical Devices industry.

What technology does Therakos is now a part of Mallinckrodt Pharmaceuticals. use?

Minus sign iconPlus sign icon
Therakos is now a part of Mallinckrodt Pharmaceuticals.'s tech stack includes ModbusCloudflareMentor GraphicsComplianceWireTensorFlowWPBakeryMinitabApache HTTP Server.

What is Therakos is now a part of Mallinckrodt Pharmaceuticals.'s email format?

Minus sign iconPlus sign icon
Therakos is now a part of Mallinckrodt Pharmaceuticals.'s email format typically follows the pattern of First.Last@therakos.com. Find more Therakos is now a part of Mallinckrodt Pharmaceuticals. email formats with LeadIQ.
Therakos is now a part of Mallinckrodt Pharmaceuticals. logo

Therakos is now a part of Mallinckrodt Pharmaceuticals.

Medical DevicesPennsylvania, United States5001-10000 Employees

Therakos operates as a medical equipment manufacturing entity that is now part of Mallinckrodt Pharmaceuticals, based in West Chester, Pennsylvania. The business sits within Mallinckrodt’s global specialty biopharmaceutical and medical imaging footprint, developing, manufacturing, marketing and distributing specialty pharmaceutical products and imaging agents. Its focus includes therapies for autoimmune and rare diseases across neurology, rheumatology, nephrology and pulmonology, along with analgesics and central nervous system drugs prescribed by office- and hospital-based physicians. This work is supported by the parent company’s strengths in managing regulated raw materials, regulatory expertise and specialized chemistry, formulation and manufacturing capabilities. 

Therakos targets healthcare providers managing complex autoimmune and rare-disease treatment needs, with a distribution and practice-facing model typical of the broader specialty pharmaceutical and imaging space. The organization aligns with Mallinckrodt’s three-segment portfolio—Specialty Brands, Specialty Generics and Global Medical Imaging—to serve its customers. In 2026, Therakos entered a three-year educational collaboration with ESOT to advance knowledge exchange through webinars, workshops and research initiatives.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
5001-10000

Section iconFunding & Financials

  • $1M - $10M

    Therakos is now a part of Mallinckrodt Pharmaceuticals.'s revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $1M - $10M

    Therakos is now a part of Mallinckrodt Pharmaceuticals.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.